Dalton Pharma Services
Cardiol has entered into an exclusive manufacturing agreement with Dalton Pharma Services for the supply of pharmaceutical cannabidiol. Dalton Pharma Services will be collaborating with Cardiol to plan and implement the necessary scale-up procedures to support the cGMP manufacture of proprietary cannabidiol formulations in preparation for clinical trials.
Dalton Pharma Services is a Health Canada approved, FDA registered, cGMP manufacturer of over 200 APIs, including pharmaceutical cannabinoids, with manufacturing capability scalable to support all stages of the regulatory process (Phase I, II, III and commercial). In 2016 and 2017, Dalton Pharma Services received the Leadership Award for Contract Manufacturing Organizations (CMO) in the following categories: Quality, Capabilities, Expertise, Compatibility, and Development.